After the human genome map was made public and techniques became simpler and universally available to study single nucleotide polymorphisms (SNPs), it became apparent that SNP's are quite common and for every hundred nucleotides in human genome sequence one SNPs is found. [1] Hence out of 3 billion nucleotides sequence that spans human genome 30 million SNP's can be expected. They have been identified in codons, introns and promoter regions of the various genes.
Biomedical researchers are now able to genotype biological samples for thousands of SNPs. Human hap map studies [2] and other studies have shown that certain SNP's of a particular gene are present either in a very high or in a very low number in different populations, i.e., SNP polymorphisms are not always random.
Whenever in biology one finds non-random events one has to explain these non-randomness in the light of evolutionary biology, i.e., mutation, natural selection, bottle necks, balanced polymorphisms, founder effects etc., These are different processes which drives the biological evolution of the genes.
Many of the SNP based studies which are spread across various journals over last one decade has one significant flaw, i.e., they are underpowered to detect the significance of the associations they claim. Because they are part of a larger region of linkage disequilibrium.
Hence it is difficult to precisely identify the SNP or SNPs that have a biological link with the phenotype.
What is the nature of association of an SNP with either a biological trait or disease process? We must understand that <10% of 3 billion nucleotides are [3] Recently discovered small interfering ribonucleic acid (RNA) based suppression of gene function [4] may also arise from intronic SNPs. Outside these two mechanisms some introns provide alternative initiation complex attachment site producing alternative version of a protein from the same gene, i.e., one gene may produce more than one proteins. [5] There could be many more other functions of intronic SNP's in altering the biology of the gene and this clearly needs to be discovered. protein and this phenomenon is due to degeneracy of genetic code, i.e., one particular amino acid may be could by more than one triplet code. [6] However, it has been demonstrated that some of these synonymous SNP changes could also be pathological and this is due to differential availability of RNAs for different triplet codons of the same amino acid. [7] In addition, association of an SNP with a disease process could be direct, i.e., the SNP is situated in crucial part of the gene like in exons, 5'and 3' end of the gene, in intron -exon boundary. We have already referred to b thalassemia mutation. Similarly SNPs in the 5'end of protein C gene affects protein C levels in a population are lower protein C level can predefine to hereditary thrombophilia. [8] Where In the present issue of the Journal several SNP based studies (restriction fragment length polymorphism [RFLP] or otherwise) have been presented. [9] [10] [11] [12] [13] [14] Number of samples studied in each of the studies are very small, i.e., between 60 and 250 samples. However, number of RFLPs studied in these papers are also one or two, hence statistically these studies may not require a P < 1 × 10 − 4 or lower to confidently talk about its significance but a P < 0.01 should be acceptable. However, SNP studies also require a hypothesis generated set of populations (samples), which should be different from hypothesis testing sets. In none of the studies stated in this issue of the Journal such an approach has been used.
One of the major questions which troubles all of us is
what to do with large number of SNP studies with small number of samples? Are these studies baseless and be related to the doubting of the history of science or they can still be made useful. Recently Schaub et al. [15] using encode consortium identified functional SNPs which may be associated with the disease phenotypes in 80% of the previously reported "possible associations".
Experimental medical statistician can stratify these studies accepting to various attributes and can join them in a meta-analysis format to make the studies more robust. More over these small studies may pave the way for a bigger and more robust study. In that case such small studies are like mini pilot studies spread in time and space.
In the present issue of the Journal Larijani et al. [16] presented an extensive meta-analysis of X-ray repair cross complementing group I gene SNP frequencies.
The study shows how meta-analysis can be refined to a degree and author talks about it in his conclusion though innumerable illustrations, forest plots, Galbraith plots and other plots are given.
However, we also have to understand that no amount of statistical jugglery can hide the weakness from the basic design of the study.
Hence, it is expected that all SNP based studies should be carefully crafted, well-designed from the beginning so that the utility of that particular study will exist at sent for some time.
